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Abstract 
Viruses that infect birds pose major threats—to the global supply of chicken, the major, universally-acceptable meat, 
and as zoonotic agents (e.g. avian influenza viruses H5N1 and H7N9). Controlling these viruses in birds as well as 
understanding their emergence into, and transmission amongst, humans will require considerable ingenuity and 
understanding of how different species defend themselves. The type I interferon-coordinated response constitutes 
the major antiviral innate defence. Although interferon was discovered in chicken cells, details of the response, par-
ticularly the identity of hundreds of stimulated genes, are far better described in mammals. Viruses induce interferon-
stimulated genes but they also regulate the expression of many hundreds of cellular metabolic and structural genes 
to facilitate their replication. This study focusses on the potentially anti-viral genes by identifying those induced just 
by interferon in primary chick embryo fibroblasts. Three transcriptomic technologies were exploited: RNA-seq, a classi-
cal 3′-biased chicken microarray and a high density, “sense target”, whole transcriptome chicken microarray, with each 
recognising 120–150 regulated genes (curated for duplication and incorrect assignment of some microarray probe-
sets). Overall, the results are considered robust because 128 of the compiled, curated list of 193 regulated genes were 
detected by two, or more, of the technologies.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
The interferon (IFN) response is one of the most impor-
tant arms of host innate immunity against virus infection 
[1, 2]. Infected cells are able to recognise foreign nucleic 
acids and induce the synthesis and secretion of type I IFN 
(IFN-α and IFN-β) and type III IFN (IFN-λ), which bind 
to receptors on the surface of neighbouring cells and trig-
ger the transcriptional regulation of genes involved in the 
antiviral state. Studies in mammals have demonstrated 
that there are several hundred such IFN-regulated genes 
(IRGs). Because the vast majority are up-regulated they 
are overwhelmingly referred to as IFN-stimulated genes 
(ISGs) so, hereafter, they will be referred to generically 
as ISGs (or specifically as chicken ISGs, ChISGs), except 
where the more generic term avoids confusion. Induc-
tion of ISGs involves the JAK/STAT signalling pathway: 
STAT1 is either recruited directly to target promoters 
for a relatively weak activation or, more commonly, is 
recruited in a complex called ISGF3 in association with 
STAT2 and IRF9 [1, 3].
ISGs are the focus of considerable current attention 
with regard to: (i) their antiviral activity, (ii) an increasing 
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appreciation of the complexity of their regulation and 
(iii) their targeting by virus-encoded modulators of 
IFN-induced responses [1, 3, 4]. These studies require 
comprehensive catalogues of the ISGs, especially where 
system-wide approaches are undertaken. Even though 
many key mammalian ISGs have been known for some 
time, it is with the relatively recent advent of transcrip-
tomic technologies that the full complement has been 
catalogued (mainly using microarrays [5]; see also Schog-
gins et al. [6]).
In contrast to the mammalian IFN system our equiva-
lent knowledge of the avian system has lagged behind. 
Although IFN was discovered in chickens in 1957 [7] the 
first chicken IFN gene was characterised in 1994 [8] and 
the key chicken ISG, PKR, was identified in 2004 [9]. The 
derivation of the chicken genome sequence, first drafted 
in 2004 [10], did not greatly advance our understand-
ing of chicken ISGs because of the incomplete nature of 
the Gallus gallus genome assembly, even at v4 (Galgal4), 
which might be partly due to the fact that the chicken 
karyotype has six pairs of macrochromosomes (but 33 
pairs of microchromosomes), and the difficulties in anno-
tating immunity genes, which are some of the most diver-
gent between mammals and birds [11]. However, it has 
become apparent that key genes of the innate immune 
system, such as the transcription factors IRF9 and one 
member of the IRF3/IRF7 dyad [12, 13; unpublished], are 
absent from avian species, indicative of significant func-
tional differences between them and mammals. Moreo-
ver, for reasons that are not understood, the cytosolic 
pattern recognition receptor, RIG-I, appears to have been 
lost from chicken as well as other galliformes [13, 14].
To generate a chicken ISG database we have compared 
data from three transcriptomic technology platforms: (i) 
the classical 3′-biased GeneChip Chicken Genome Array 
(32K; Affymetrix, High Wycombe, UK), (ii) the Chicken 
Gene 1.0 Sense Target (ST) whole transcriptome Array 
(Affymetrix) and (iii) Illumina (Little Chesterford, UK) 
RNA-seq. This three-way comparison allowed a high 
level of cross-validation of data from each technology, 
beyond what would normally be achieved by qRT-PCR. 
It also allows subsequent studies, constrained to use any 
particular technology, to be more broadly compared. 
We monitored IRG expression in chicken embryo fibro-
blast (CEF) induced for 6 h with 1000 units recombinant 
chicken IFN-α (rChIFN1; hereafter routinely referred 
to as IFN), a time chosen to reflect predominantly pri-
mary signalling targets. The expression data for selected 
genes were also validated by PCR and qRT-PCR. Over-
lapping data show generally high degrees of concord-
ance in the identity of the IRGs and their relative levels of 
regulation by IFN, with disparity mainly where multiple 
microarray probes exist for single genes. The study was 
presented in a preliminary form as a poster at the Inter-
national Cytokine and Interferon Society (ICIS) meeting 
(“Cytokines 2015”; October 11–14, 2015) in Bamberg, 
Germany [15].
Materials and methods
Culture, infection and harvesting of CEF for microarray
Freshly isolated CEF were provided by the former Insti-
tute for Animal Health (Compton, UK, now The Pirbright 
Institute, Pirbright, UK). Cells were seeded in T25 flasks 
(Greiner Bio One, Kremsmünster, Austria; 5.6  ×  106 
cells/flask) and cultured overnight in 5.5  mL 199 media 
(Gibco Thermo Fisher Scientific, Paisley, UK) supple-
mented with 8% heat-inactivated newborn bovine serum 
(NBCS; Gibco), 10% tryptose phosphate broth (TPB; 
Sigma-Aldrich, Gillingham, UK), 2% nystatin (Sigma-
Aldrich) and 0.1% penicillin streptomycin (Gibco).
Treatment with IFN
Recombinant chicken IFN-α (rChIFN1) was prepared as 
previously reported [16] and was added in culture media 
to a final concentration of 1000 units/mL. Confluent cells 
were treated with IFN or mock-treated and incubated for 
six hours before harvesting. Cells were stored at −80 °C 
in RNAlater (Sigma-Aldrich) until RNA extraction. The 
experiment was repeated in triplicate with three different 
batches of CEF.
RNA extraction and processing of samples for microarray
Total RNA was extracted from cells using an RNeasy kit 
(Qiagen, Crawley, UK) according to the manufacturer’s 
instructions. On-column DNA digestion was performed 
using RNase-free DNase (Qiagen) to remove contaminat-
ing genomic DNA. RNA samples were quantified using a 
Nanodrop Spectrophotometer (Thermo Fisher Scientific, 
Paisley, UK) and checked for quality using a 2100 Bioana-
lyzer (Agilent Technologies, Wokingham, UK). All RNA 
samples had an RNA integrity number (RIN) ≥9.6.
RNA samples were processed for microarray with the 
GeneChip® Chicken Genome Array (Affymetrix) using 
the GeneChip® 3′ IVT Express Kit (Affymetrix) or for 
microarray with the Chicken Gene 1.0 ST Array (Affy-
metrix) using the Ambion (Paisley, UK) WT Expression 
Kit for Affymetrix GeneChip® Whole Transcript (WT) 
Expression Arrays (Ambion) and the GeneChip WT Ter-
minal Labelling and Controls Kit (Ambion), following the 
manufacturers’ instructions, as described previously [17].
Total RNA (100  ng) was used as input and quality 
checks were performed using the 2100 Bioanalyzer at all 
stages suggested by the manufacturer. RNA samples were 
processed in two batches of 18 but batch mixing was 
used at every stage to avoid creating experimental bias. 
Hybridisation of RNA to chips and scanning of arrays 
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was performed by the Medical Research Council’s Clini-
cal Sciences Centre (CSC) Genomics Laboratory (Ham-
mersmith Hospital, London, UK). RNA was hybridised to 
GeneChip Chicken Genome Array chips (Affymetrix) in 
a GeneChip Hybridization Oven (Affymetrix), the chips 
were stained and washed on a GeneChip Fluidics Station 
450 (Affymetrix), and the arrays were scanned in a Gene-
Chip Scanner 3000 7G with autoloader (Affymetrix).
Validation of microarray data for IFN‑responsive genes 
by quantitative real‑time PCR (qRT‑PCR)
cDNA was synthesised from RNA samples from 
untreated and IFN-treated CEF using the QuantiTect® 
Reverse Transcriptase system (Qiagen) according to the 
manufacturer’s instructions. The cDNA was used as a 
template in 25 μL RT-PCR reactions containing: 19.35 μL 
nuclease-free distilled H2O (Gibco), 2.5  μL 10× buffer 
(Invitrogen) 0.75  μL MgCl2 (Invitrogen), 0.2  μL dNTPs 
(25  mm; Sigma-Aldrich), 0.5  μL each of forward and 
reverse primers (20  pmol/μL; Invitrogen Thermo Fisher 
Scientific, Paisley, UK), 0.2 μL Taq DNA polymerase (Inv-
itrogen) and 1 μL template cDNA. Primer sequences are 
shown in Table 1.
qRT-PCR was performed using MESA GREEN qPCR 
MasterMix Plus for SYBR® Assay I dTTP (Eurogen-
tec, Southampton, UK) according to the manufacturer’s 
instructions. A final volume of 10  μL per reaction was 
used, with 1 μL cDNA diluted 1:10 in nuclease-free H2O 
as a template. Primers were used at a final concentra-
tion of 300 nM. Primer sequences are shown in Table 1. 
Reactions were performed on an ABI-7900HT Fast Real-
Time PCR System (Applied Biosystems, Warrington, 
UK) using the following programme: 95 °C for 5 min; 40 
cycles of 95 °C for 15 s, 57 °C for 20 s, 72 °C for 20 s; 95 °C 
for 15  s; and 60  °C for 15  s. Data were analysed using 
SDS 2.3 and RQ Manager software (Applied Biosystems). 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
was used as a reference gene. All target gene expres-
sion levels were calculated relative to GAPDH expres-
sion levels and the target gene expression level in −2  h 
uninfected CEF using the comparative CT method (also 
referred to as the 2−ΔΔCT method).
RNA‑seq
Triplicate untreated (control) and IFN-treated CEF were 
processed for transcriptome analysis by RNA-seq. The 
cell samples used were identical to those used for the 
microarray analyses. Total RNA was extracted as for 
microarrays (above) and RNA libraries were prepared for 
deep sequencing using the TruSeq RNA Sample Prepa-
ration Kit (Illumina) according to the manufacturer’s 
instructions. Total RNA (2.5  μg) was used as an input 
for each library. A total of six RNA adapter indices were 
randomly assigned to the 12 samples to allow multiplex-
ing of libraries. At the end of the protocol, libraries were 
quantified using a Nanodrop Spectrophotometer and 
checked for quality using a 2100 Bioanalyzer High Sen-
sitivity DNA chip (Agilent Technologies). RNA library 
qPCR quantification, multiplexing and sequencing was 
performed by the Medical Research Council’s Clinical 
Sciences Centre (CSC) Genomics Laboratory, Hammer-
smith Hospital, London, UK. Libraries were quantified 
using the KAPA Biosystems (London, UK) library quan-
tification kit (KK4824) on an ABI 7500 FAST qPCR 
machine (Applied Biosystems). Libraries were then 
diluted to a 2  nM stock solution, pooled for multiplex-
ing, denatured and diluted to a final molarity of 20 pM. 
Libraries were loaded on to the flow cell (8–16  pM per 
lane) for clustering and cluster generation was performed 
by the Illumina cBot using version 3 kits. Sequencing of 
the flow cell was then carried out on the Illumina HiSeq 
2000 using the version 3 kits. Data were processed using 
Table 1 Primers used to quantify gene expression in mock or IFN-treated CEF using real-time qRT-PCR
Gene Accession number Forward primer (5′–3′) Reverse primer (5′–3′)
GAPDH NM_204305.1 GGCACTGTCAAGGCTGAGAA TGCATCTGCCCATTTGATGT
IFNβ NM_001024836.1 CAGTCTCCAGGGATGCACAG GAGAAGGTGGTGGTGAGAGC
MX1 NM_204609.1 CACACCCAACTGTCAGCGAT ATGTCCGAAACTCTCTGCGG
IFIT5 XM_421662.4 TGCTTCACCAGCTAGGACTCTGC TGGCTTTTGCTCTGTCACCACTTTG
ZC3HAV1 NM_001012938.1 TCGGCGCCTCTCTACGCCAT TCAGTCCACTGGCCGTGGTCA
IRF8 NM_205416.1 ACAAGCAGGGCATCTTCATC TGTTCCCACTCCAGAAGACC
SOCS1 NM_001137648.1 CTGCTGGATGCCTGCGGCTT GGGCCCGGTCGCGGTTTTAA
IL15 NM_204571.1 CACTGTAAGTGGTCAGACGTTCTGA GGTTCCTGGCATTCTATATCCTCGT
RSAD2 XM_426208.4 GGACAAGGACGAGACAGTTCC TCCCGCCTCCTTAAGCATTG
TRIM25 XM_415653.5 TCAAGAGTCCCACCCTTCCA AGCAGCTCAATGGACAGCAT
LGP2 HQ845773.1 ATCTCGCGGCATTGTCTTCA CTGCTGCTCATTCTGGGTCA
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RTA version 1.12.4.2, with default filter and quality set-
tings. The reads were demultiplexed (allowing no mis-
matches in the index sequence) with CASAVA 1.8.1.
Bioinformatic analysis
Microarray data were processed using workflows in 
GENESPRING™ (Agilent) and PARTEK™ (Partek Inc., St 
Louis, MO, USA) commercial software suites.
Data (.CEL files) were analysed and statistically fil-
tered using either Partek Genomic Suite 6.6 (Partek GS) 
or Genespring version 7.2 (Agilent Technologies) soft-
ware. Input files were normalized with either GCRMA or 
Genespring algorithms for gene array on core metaprobe-
sets. A one-way ANOVA was performed using either 
software across all samples. Statistically significant genes 
were identified using mixed model analysis of variance 
with a false discovery rate (Benjamini–Hochberg test) of 
P < 0.05. Fold-change values <±3.0 were removed.
RNA-seq data were imported into CLC bio’s Genomics 
Workbench (CLC Bio, Aarhus, Denmark; now Qiagen), 
quality-controlled and thereafter processed using that 
package (versions 6 and 7).
After quality control, the reads were subjected to qual-
ity trimming then mapped against ENSEMBL Galgal4 
annotated genes (release 75 [18]) for quantitative analy-
sis of expression. Fold change and False Discovery Rates 
(FDR) were calculated using Kal’s Z test [19], with pooled 
data, or Baggerly’s test [20], using separate triplicates.
Results
Initially, we used the 32K GeneChip® Chicken Genome 
Array (Affymetrix) because, as well as displaying probes 
for 32 773 chicken transcripts, it displays probes for 684 
transcripts from 17 different viral pathogens of chickens, 
which offers advantages to those studying virus infections 
in a chicken background. Subsequently, we used the more 
refined Chicken Gene 1.0 ST Array (Affymetrix) because 
it offers a higher probe density against 18 214 chicken 
genes and should allow detection of transcript isoforms, 
including non-polyadenylated and alternatively polyade-
nylated, though it does not include probes for viral genes.
Separate weekly batches of CEF, produced from pools 
of eggs from the same flock (Rhode Island Red) held in 
SPF-like conditions at the former Compton Laboratory 
of the Institute for Animal Health (now The Pirbright 
Laboratory) served as biological replicates. Principal 
component analysis of the microarray data (data not 
shown) indicated limited variation between batches so, 
thereafter, biological triplicates were used routinely.
IRGs were identified from expression analysis data 
determined using the 32K GeneChip following IFN 
treatment (1000  units, 6  h) of CEF. After quantile 
normalization, significant hits were identified with 
GENESPRING using an unpaired T test with asymptotic 
p-value computation and Benjamini–Hochberg multiple 
testing correction to generate false discovery rates (FDR). 
A matrix of FDR (from <0.001 to 1) plotted against fold 
change (FC; from 1.0 to >3) is shown in Table 2. A rela-
tively conservative FDR of <0.01 returned 250 differen-
tially expressed probesets. Overlaying this with a value 
for FC for which changes in expression might reasonably 
be expected to be readily and reliably assayed using other 
technologies, namely >3, reduced the number of selected, 
significant probesets to a manageable 181 (180 up, 1 
down). These settings were therefore chosen for further 
analysis. For 23 of these probe sets, no currently recog-
nised genes were automatically assigned. Of the remain-
ing 158 probe sets, 29 were assigned to genes recognised 
in duplicate by other probe sets. Consequently 129 rec-
ognised genes were identified as differentially expressed 
(the down-regulated transcript was not, at that time, 
assigned to a recognised gene).
With the Chicken Gene 1.0 ST Array, 157 probe sets 
demonstrated differential expression (156 up, 1 down) at 
the same settings (FC > 3, FDR < 0.01). Amongst these, 
there were five duplicated probe sets and 27 that were 
not automatically assigned to recognised genes therefore 
125 recognised genes were uniquely identified as differ-
entially regulated.
Illumina RNA-seq yielded a total of 170 million reads 
(100 bases; paired) for the mock-treated CEF tripli-
cate samples and 167 million for the IFN-treated sam-
ples. Upon quality trimming and mapping to ENSEMBL 
Galgal4 annotated genes (release 75), using CLC Bio’s 
Genomic Workbench, 138 recognised genes were iden-
tified as differentially regulated (137 up, 1 down) using 
Kal’s proportion-based Z test [19; as implemented in 
the CLC Bio package] at the same settings (FC  >  3, 
FDR < 0.01). Kal’s is performed on the pooled reads from 
IFN-treated and untreated samples. It is perhaps, there-
fore, more widely applicable; it also returned a number of 
IRGs comparable to those returned by the microarrays. 
Triplicate-based analysis using Baggerly’s proportion-
based Beta-binomial test [20; as implemented in the CLC 
Bio package] at the same settings (FC  >  3, FDR  <  0.01) 
returned an additional 37 up-regulated genes.
Comparison of the complete raw gene lists from the 
three technologies using the most compatible identifier 
(essentially the Gene Symbol) with an online Venn Dia-
gram tool (Venn Diagram Generator; [21]) demonstrated 
that 233 recognised genes were identified as differen-
tially regulated. Of these, 51 were identified in common 
by all three technologies and a further 57 were identified 
by two out of three technologies, meaning that 108 were 
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identified by at least two technologies. A total of 125 
were therefore each identified only by individual technol-
ogies (Figure 1A).
As well as comparing the identities of the differen-
tially regulated genes, the correlation of expression of the 
genes identified by the different platforms was examined 
in terms of both level and rank of FC (Figures  2A  and 
B). For instance, comparing RNA-seq data with the 32K 
GeneChip data, Spearman correlation values were 0.93 
for FC level and rank. Considering the current state of 
assembly and annotation of the chicken genome, the cor-
relation of ISGs in terms of gene identity as well as the 
level and rank of induction as indicated by all three tech-
nology platforms is reassuring. Nevertheless the platform 
transcriptomic data were validated for selected genes by 
RT-PCR (data not shown) and by qRT-PCR (Figure 3A). 
A 6 h time point was chosen for microarray and RNA-
seq analysis of IFN treatment as it has been widely used 
Table 2 Matrix showing significant hits from microarray (Affymetrix 32K GeneChip Chicken Genome Array) analysis of 
chicken embryo fibroblasts (CEF) treated with recombinant chicken IFN1 (1000 units, 6 h)
Numbers of significant genes are indicated for fold change in expression from >1.1 to >3 and from false discovery rate (FDR) <0.001 to <0.05 (unpaired T test with 
asymptotic p value computation and Benjamini–Hochberg multiple testing correction).
Fold change FDR
All <0.05 <0.02 <0.01 <0.005 <0.001
All 38 285 945 414 250 150 24
>1.1 17 636 942 414 250 150 24
>1.5 1965 676 363 232 146 23
>2.0 677 458 296 206 135 22
>3.0 354 306 235 181 123 22
Expected by chance 47 8 2 0 0
RNA-seq Kals 
FC>3 FDR<0.01
n=138
3’ microarray 
FC>3 FDR<0.01
n=181 (129 recognised)
ST array 
FC>3 FDR<0.01
n=157 
(125 recognised)
233 unique IRGs
36
25
3415
51
17
55
23
9
2319
70
20
29
17
7
1923
72
26
29
193 unique IRGs 193 unique IRGs
A B C
Figure 1 Correlation of ISGs identified as significant by RNA-seq and microarray. Venn diagrams showing correlation of significant ISGs 
(FC ≥ 3; FDR ≤ 0.01, unless stated otherwise) for: (i) Illumina 100b paired-end RNA-seq, (ii) Affymetrix 32K GeneChip Chicken Genome Array and 
(iii) Chicken Gene 1.0 ST Array, following induction of CEF for 6 h with 1000 units of rChIFN1. (A) Total hits (“n =”) shown for each technology; those 
corresponding to Galgal4 assembly Gene IDs are shown in brackets (“recognised”)—RNA-seq hits all represent Galgal4 mapped genes. (B) Hits 
from array technologies were manually curated to maximise numbers of corresponding genes. (C) Curated array hits shown in (B) that are present 
amongst RNA-seq hits, but at lower levels of significance, were transferred to the respective RNA-seq-overlapping sectors. Total genes are shown for 
(A–C).
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and is known to result in significant levels of a broad 
range of ISGs in mammals, making it suitable for defin-
ing the chicken interferome. Use of this single time point 
does not, however, provide unequivocal insight into 
mechanistic interpretation of ISG induction; for instance, 
it does not discriminate between strictly ISRE-depend-
ent induction of ISGs and ISRE-independent induction 
of ISGs by mechanisms that might include immediate 
high-level induction of IRF1, which has been observed 
in mammalian systems [22–24]. Kinetic analysis of the 
induction of expression of a subset of ISGs was therefore 
conducted at 45, 90, 180 and 360 min post application of 
IFN (see Figure  3B). Even among highly-induced ISGs, 
different temporal profiles were observed, from the rapid 
accumulation of IFIT5 (1000-fold by 90 min) and RSAD2 
(which remain at steady levels to 360 min) to the stead-
ier, sustained accumulation of Mx and the more mod-
estly induced STAT1; with LGP2 and TRIM25 peaking 
at 180 min. Although differences in mRNA stability and 
turnover will influence the profiles, this identification of 
the ISGs will allow detailed analysis of their promoters to 
investigate elements (and the factors that bind them) that 
contribute to the complexity of the observed induction 
patterns.
Discussion
Of the 51 IRGs initially identified by all three technolo-
gies, 47 had mammalian equivalents that are known 
as ISGs from human or mouse according to the “Inter-
ferome” database (v2.01; [25, 26]). Those not listed in 
Interferome were: EPB41L3, IFI27L2, OLFML1 and 
TMEM168. Of the 57 IRGs initially identified by two out 
of the three technologies, 29 have mammalian equiva-
lents known as human or mouse ISGs. Therefore, of the 
108 ChISGs identified initially by at least two technolo-
gies, 76 were equivalent to known mammalian ISGs. For 
those ChISGs identified by single technologies, 12 of the 
55 identified by RNAseq (L1), 10 of the 36 identified by 
the 32K Genechip (L2) and 12 of the 34 identified by the 
ST Array (L3) were listed in Interferome. This added a 
further 34 candidate ChISGs (a total of 110) with known 
mammalian ISG equivalents (as recognised by the Inter-
ferome database). The majority of ChISGs for which 
mammalian equivalents cannot be found in the Interfer-
ome database (all 4 from the “common” ISGs, 23 of 28 
identified by at least two technologies as well as 21 out 
of 43 for L1, 15 out of 26 for L2 and 13 out of 22 for L3) 
have gene equivalents in the mammalian genome data-
bases (see Additional files 1 and 2); see also the “ChISG 
Browser” [Tomlinson, unpublished; 27]). This suggests 
either that the mammalian equivalents are ISGs but that 
they are not included as such in Interferome or that they 
are not ISGs in mammals.
The raw lists were refined by manual “curation”, allow-
ing for synonyms of recognised genes (for instance 
ISG12-2 versus ISG12(2)) and, after bioinformatic analy-
sis using BLAST, etc., assigning recognised gene identi-
fiers to probe sets that previously lacked them. At the end 
of this process (Figure  1B; Additional files 1, 2), it was 
apparent that some (n = 12) differentially regulated genes 
identified by the microarrays were also identified as dif-
ferentially regulated by RNA-seq but that they fell outside 
of the strict FC > 3 and FDR < 0.01 parameters, reflect-
ing unsurprising disparity in the sensitivity of the three 
technologies. Those genes that were expressed down to 
FC > 2.5 or with an FDR up to < 0.05 were, therefore, also 
incorporated to produce a final list (Figure 1C; Additional 
files 1, 2).
It is obvious that this manual curation of the data, to 
allow for alternative Gene ID nomenclature used by 
the three technologies and for differences in sensitivity, 
Figure 2 Comparison of expression level and rank of signifi-
cant ISGs identified by RNA-seq and microarrays. Spearman 
correlation plots for significant ISGs from: (i) Illumina 100b paired-end 
RNA-seq and (ii) Affymetrix 32K GeneChip Chicken Genome Array, 
following induction of CEF for 6 h with 1000 units of rChIFN1, by FC 
(A) and by Rank (B).
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introduced minor changes to the figures from the auto-
matic comparisons cited above (Figure 1; Additional files 
1, 2). Curation, therefore, reduced the number of IRGs 
from 233 to 193. It also increased the number of differen-
tially expressed genes detected by two out of three tech-
nologies from 108 to 118 (compare Figures  1A  and B). 
Relaxing the criteria for detection of differentially regu-
lated genes by RNA-seq (to FC > 2.5 and/or FDR < 0.05) 
further increased the number of genes detected by all 
three technologies from 70 to 72 (representing 37%) 
or by at least two of the technologies from 118 to 128 
(66%), leaving 65 genes detected by single technologies 
(compare Figures  1B  and C), with 29 of those detected 
by RNA-seq alone (using the Kal’s test, at FC > 3.0 and 
FDR < 0.01; Additional files 1, 2).
Of the 37 additional ISGs identified by RNA-seq as 
significant (FC  >  3 FDR  <  0.01) by the more sensitive 
Baggerly’s test but not by Kal’s (Table  3), two were also 
identified as significant by Kal’s using the relaxed crite-
ria (FDR < 0.05). Baggerly’s, therefore, identified 35 ISGs 
additional to those described in the above analyses using 
RNA-seq (Kal’s analysis) and the microarrays (Table 3).
A
B
Figure 3 qRT-PCR validation and kinetic analysis of ISG expression. (A) Validation of RNA-seq and Microarray ISGs by qRT-PCR of CEF treated 
with recombinant chicken IFN1 (1000 units, 6 h). (B) Kinetics of expression of selected ISGs assayed by qRT-PCR following treatment of CEF with 
recombinant chicken IFN1 (1000 units) for 45, 90, 180 or 360 min. ISGs showing similar kinetic expression profiles are paired vertically.
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Comparison of technology platforms
Analysis of RNA-seq data depends directly on the extant 
annotated genome sequence. Perhaps not surprisingly 
therefore, RNA-seq identified the largest proportion of 
genes amongst the set of 193 unique IRGs that we com-
piled (150; 78%). Nevertheless, the microarrays each 
identified 63% of the genes (122 and 121). Congruence 
was highest, and almost identical, between RNA-seq 
and each microarray (98 and 95; 51  ±  1%; all percent-
ages referring to the total of 193 unique IRGs). Between 
microarrays it fell to 41% (79). For two-way-only com-
parisons, the distribution of unique genes between the 
microarrays was symmetrical (42 and 43; 22%). Between 
RNA-seq and each microarray, unique genes were biased 
>2-fold towards RNA-seq: 52 (27%) versus 24 (12%) 
against the Genechip and 55 (28%) versus 26 (13%) 
against the ST Array.
Clearly in simple terms of numbers of IRGs identified, 
RNA-seq outperforms the microarrays. This is probably 
attributable to the historic nature of the array design 
based on earlier genome assemblies and annotations, 
with consequent effects on overall coverage (which might 
disproportionately affect conditionally expressed genes 
such as those of the innate immune responses). Never-
theless, the ability of microarrays to quantify expression 
of 50% (about 100) of such a large pool of important 
genes will often prove sufficient for the experimental 
objectives where other considerations might affect the 
choice of technology (see below).
Moving away from actual numbers of genes, it is worth 
noting that deeper analysis (in the form of validation by 
alternative approaches) will, by definition, be required to 
determine which of the genes identified uniquely as IRGs 
by individual technologies are actually IRGs.
Identification of ISGs not annotated on the current 
genome
Genomic loci for each of the predicted ISGs were visually 
inspected using Genomic Workbench’s genome browser, 
displaying tracks showing: gene, transcript, exon and 
ORF annotations for the current chicken genome build 
as well as read-mapping for control and IFN-treated 
reads [27]. On occasions, such inspection revealed 
the presence of non-annotated, inducibly-transcribed 
regions, representing exons, whole genes or even gene 
families. Examples include those previously described 
at the chicken IFITM locus [28; data not shown], at 
the HERC locus (described below) or downstream of 
CCL19 (LOC100857191; “C–C motif chemokine 26-like”; 
Figure 4). Systematic analysis of these ISGs is outside the 
scope of this manuscript but the data deposited from 
this study (European Nucleotide Archive (ENA) study 
number PRJEB7620 [44])  will facilitate ongoing study 
and improved annotation. In some cases, although not 
currently annotated on the ENSEMBL chicken genome, 
the genes have IDs in NCBI and were identified as ISGs 
by one of the microarrays. Examples of these include 
LOC415756, LOC415922 (“guanylate-binding protein 
4-like”) and LOC422513 (“hect domain and RLD 4-like”, a 
member of the HERC family, discussed below).
Table 3 ChISGs identified by RNA-seq using Baggerly’s 
test but not Kal’s test using standard criteria (FC  >  3 or 
FDR < 0.01)
a ChISGs significant by Kal’s Z test under relaxed criteria (FDR < 0.05).
Feature ID Baggerley’s 
weighted  
proportions FC
Baggerley’s 
FDR p value 
correction
Kal’s relaxed 
FDR < 0.05a
FAM26F 148 0.0000 Yes
THEMIS2 118 0.0004
ENSGALG00000026152 55 0.0000
ENSGALG00000005148 54 0.0043
ENSGALG00000003110 52 0.0050
IL4I1 26 0.0040
C1orf168 24 0.0001
SPIRE2 18 0.0041
HRH1 17 0.0001
AZIN2 14 0.0000
ENSGALG00000029181 14 0.0000
ENSGALG00000001629 12 0.0001
B3GNT4 9 0.0000
GDPD4 8 0.0000
ATP6V1G3 7 0.0002
DUSP15 7 0.0002
IKBKE 7 0.0001
ANGPTL7 6 0.0000
ARHGEF28 6 0.0004
KCNJ5 6 0.0000
CHRD 5 0.0000 Yes
ENSGALG00000002823 5 0.0005
ENSGALG00000004772 5 0.0000
ENSGALG00000006325 5 0.0000
ENSGALG00000027955 5 0.0000
FUT10 5 0.0000
TOR4A 5 0.0001
C1QTNF1 4 0.0000
CYBRD1 4 0.0000
ENSGALG00000000819 4 0.0028
ENSGALG00000020899 4 0.0000
ISLR 4 0.0000
JAM2 4 0.0000
KIAA0226 4 0.0028
MALL 4 0.0002
MAOA 4 0.0000
RBM43 4 0.0015
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Identification of ISGs not present in the current genome
About 10% of the reads from CEFS did not map to the 
current chicken genome. The unmapped reads com-
bined from the control and IFN-treated samples were 
assembled into contigs using the de novo assembly func-
tion of Genomic Workbench. The RNA-seq function 
of Genomic Workbench was then used to quantitate 
expression of the contigs in control and IFN-treated sam-
ples. One of the most highly-expressed contigs was one 
which, when analysed by BLAST, proved to represent 
a homologue of STAT2, which is missing from the cur-
rent ENSEMBL annotated reference chicken genome 
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Figure 4 Gene-level visualisation of RNA-seq reads mapped to the chicken genome. Annotated CLC Bio Genomic Workbench 
views of chicken chromosome Z (A) and 4 (B) showing the loci around homologues of CCL19 (ENSGALG00000028256) (A) and PYURF 
(ENSGALG00000026229) (B). Each panel shows tracks for genes (labeled with Galgal4—annotated names), untranslated regions (UTR), cod-
ing sequences (CDS) and mRNA transcripts. Locations of unannotated NCBI Galgal5 Refseq genes LOC 1008571891 (A) and LOC422513 (B) are 
indicated. RNA-seq reads from untreated and IFN-treated CEF (6 h, 1000 units) are shown mapped to the genome in the uppermost and lowest 
tracks, respectively, in each panel (totals mapped to the chromosome are indicated to the left of these tracks). The levels of basal and peak RNA-read 
mappings are shown to the right of the tracks under “Scale”. Comparison of these figures in conjunction with the size of the peaks allows visual 
estimates of the levels of differential expression for individual exons (which can be compared with the formal numerical analyses). For instance, 
IL11RA (A) as well as CCGN2 and HERC3 (B) show no significant regulation by IFN. In contrast, CCL19 and unannotated LOC100857191 in (A) show 
significant upregulation (96-fold—but with an FDR of 0.031 it fell outside the cut-off for Kal’s analysis and, because of its very low basal expression, 
was not returned by Baggerly’s). In (B) PYURF shows 24-fold suppression by IFN but the sequence surrounding PYURF shows 87-fold induction 
from the right-hand end of the unannotated, antisense LOC422513 and considerably higher upregulation from the left-hand end (due to its lower 
uninduced levels), consistent with these representing homologues of IFN-inducible human genes HERC6 and HERC5.
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assembly (Galgal4; release 84), though at NCBI it has 
recently been placed as a Refseq gene on chromosome 33 
in the new assembly Galgal5 (an annotated form of which 
has not yet been released and is currently not scheduled 
for release). The de novo assembled contig sequence was 
used to derive primers for RT-PCR; characterisation of 
chicken STAT2 will be reported elsewhere.
Interferon down‑regulated gene expression
The data on differential expression showed an overwhelm-
ing over-representation of genes up-regulated by IFN. For 
each of the technologies, only one gene was detected as 
down-regulated. Corresponding GeneIDs were PYURF 
(PIGY upstream reading frame; ENSGALG00000026229) 
for RNA-seq and PIGY (phosphatidylinositol glycan 
anchor biosynthesis, class Y; NCBI GeneID: 101748971) 
for the ST array. The down-regulated 32K GeneChip probe 
(Gga.8802.1.S1_at), though not mapped to a known gene 
at the time of initial processing, according to the Affyme-
trix NetAffx™ Analysis Center [29] is now also assigned as 
PYURF. In humans, PIGY and PYURF represent different 
open reading frames on the same spliced transcript of a 
gene on Hs chromosome 4 located downstream of HERC6 
then HERC5. The PYURF/PIGY gene is overlapped on 
the opposite strand by HERC3, which extends down-
stream to be followed by FAM13A. Similarly, the chicken 
PIGY (NCBI) and PYURF (Ensembl) genes map to a locus 
lying upstream of HERC3 then FAM13A on Gg chromo-
some 4 (see Figure 4), with HERC-like LOC422513 (“hect 
domain and RLD 4-like”) starting upstream but span-
ning and extending downstream of the chicken PYURF. 
Our RNA-seq data (Figure  4) indicate that this locus is 
poorly annotated and demonstrates complex regulation 
of the component genes by IFN. Thus, although the PIGY/
PYURF transcript is down-regulated by IFN, as recorded 
by all three technologies, it appears to be closely flanked 
upstream and downstream by still unannotated multiple 
exons that are clearly strongly induced by IFN (Figure 4). 
Sequences within these upstream and downstream regions 
(which are represented by the single NCBI Refseq (Gal-
gal5) gene, LOC422513, but appear as though they may 
represent two separate genes, Figure  4) bear homology 
with genes of the HERC family, consistent with the fact 
that HERC5 neighbours the human PIGY/PYURF gene 
and that HERC3 neighbours the chicken PIGY/PYURF 
gene. The chicken HERC3 gene shows no evidence of 
induction by IFN.
Description of the interferon-inducibility of the ChISGs 
serves as the first step in understanding the regulation of 
their expression and their role in anti-viral (and poten-
tially broader anti-microbial) activities. There is con-
siderable current interest in the antiviral responses of 
particular cell types, particularly those of the lymphoid, 
myeloid and dendritic lineages. However, the definition 
of a wide variety of these cell types is not so advanced in 
avian species so we felt it best to produce baseline data 
for readily available, primary cells, namely chick embryo 
fibroblasts (CEF) as they are highly responsive to IFN. 
They also remain important for commercial production of 
vaccine viruses (including human vaccines) as well as for 
the routine isolation and diagnosis of avian pathogens.
Given the currently incomplete nature of the chicken 
genome assembly (even at Galgal5) and of its annotation 
(as currently available for Galgal4 and even as awaited for 
Galgal5) it is inevitable that updates will continue to be 
released but the primary data reported here, and pub-
licly-available, for microarrays and RNA-seq, can always 
be applied to updated microarray assignments as well as 
to subsequent genome assemblies and annotations.
All things being equal, RNA-seq would seem to be the 
method of choice for transcriptomic analysis of chicken 
IFN responses, particularly given its ability to produce 
high-resolution quantitative and qualitative data. Moreo-
ver the data are readily portable and can be easily mined 
by others with different research focus. They can also be 
applied immediately to newly released genome assem-
blies and annotations (whether global or local), whereas 
microarray analysis must await the generation of annota-
tion updates for each technology.
However, although the cost of sequencing has fallen, 
and will probably continue to do so, there remain consid-
erable overheads to handling large data sets from exten-
sive, complicated experiments, especially in terms of 
computing and data storage capacity, as well as speed of 
processing and archiving. For such experiments, micro-
arrays continue to offer a tractable approach, capable of 
quickly quantifying and comparing the expression of the 
central core of IRGs producing relatively compact data 
for rapid analysis and easy archiving.
Induction of innate responses with PAMPS will trig-
ger different or broader ranges of responses by virtue 
of the fact that they will trigger other or more pathways 
than just the IFN-pathway. For instance we (Giotis et al. 
unpublished) and others [12] have begun to analyse the 
responses induced by the dsRNA analogue poly[I:C]. 
Regulation of ISG expression might affect the innate 
responses observed in different cell lines or tissues so it 
will be important to understand the mechanisms involved. 
Additionally, we have observed suppression of ISG induc-
tion in the spontaneously immortalized chicken fibroblast 
cell line, DF-1 [30], due to their enhanced basal expression 
of the regulatory ISG, SOCS1 (Giotis et al., unpublished). 
Identification of the ISGs means that their promoters, 
enhancers and other regulatory elements can be system-
atically analysed to help understand the complex kinetics 
of expression of their expression (Figure 4).
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Several studies have investigated changes in host gene 
expression in response to infection in vivo or in culture 
with particular avian viruses [31–39]. Although many of 
these genes will represent innate (and potentially antivi-
ral) host responses, the majority will be involved in the 
metabolic, cell cycle and ultrastructural changes that the 
virus has to induce to facilitate replication. Furthermore, 
it is not unusual for viruses to modulate the expression 
of signalling molecules key to the antiviral responses or 
of antiviral effectors themselves. For instance, we have 
shown that even an attenuated strain of fowlpox virus 
blocks induction of IFN-β (ChIFN2) and is highly resist-
ant to the antiviral activity induced by IFN [16, 40].
The results of existing and future studies of infec-
tion in  vivo or in culture with particular avian viruses 
can now be compared with data presented here for ISG 
induction by IFN to look for evidence of modulation 
of ISG expression by viruses, whether that be modula-
tion of individual ISGs, subsets [4] or the complete set. 
For instance, fowlpox virus blocks essentially all ISG 
expression but a mutant defective in the fpv012 ankyrin 
repeat/F-box protein identified by Laidlaw et  al. [40] 
induces modest levels of a subset of the ISGs (Giotis 
et  al., unpublished). Such analyses can be extended to 
important avian zoonotic viruses and pathogens with 
huge impact on the global poultry industry. Although 
this study relates to type I IFN, extensive comparison 
with the effects of type III IFN could now be conducted, 
extending on the qRT-PCR comparison made by Mas-
uda et  al., who looked at induction of Mx and OAS by 
IFN-β, IFN-γ and IFN-λ [41].
Additional files
Additional file 1. Table of curated ChISGs identified by individual 
or multiple technologies. (1) An asterisk indicates a Gene ID not anno-
tated in ENSEMBL. (2) Technologies identifying significant IRGs are listed 
as ‘1’ RNA-seq (using Kal’s Z test); ‘2’ Affymetrix 32K GeneChip Chicken 
Genome Array and ‘3’ Chicken Gene 1.0 ST Array’. ChISGs significant by one 
or both microarrays and RNA-seq using Kal’s Z test under relaxed criteria 
(FC > 2.5 or FDR < 0.05) are indicated by ‘(1)’. A plus after the technology 
identifier indicates that IFN-induced RNA-seq read density was observed 
at the location of the unannotated gene. (3) Indicates whether homo-
logues of the ChISG identified are listed in the Interferome website as 
induced by interferon in Homo sapiens (Hs), Mus musculus (Mm), both (Hs/
Mm), or neither (***).
Additional file 2. Detailed information on ChISGs identified by 
RNA-seq, and microarray technologies (1). Technologies identifying 
significant IRGs are listed as “1” RNA-seq (using Kal’s Z test); “2” Affymetrix 
32K GeneChip Chicken Genome Array and “3” Chicken Gene 1.0 ST Array’. 
ChISGs significant by one or both microarrays and RNA-seq using Kal’s Z 
test under relaxed criteria (FC > 2.5 or FDR < 0.05) are indicated by “(1)”. “+” 
after the technology identifier indicates that IFN-induced RNA-seq read 
density was observed at the location of the unannotated gene. (2) Inter-
ferome status [45]. (3) Human homologue data (HUGO) [46]. (4) Mouse 
orthologue data (MGI) [47].
Abbreviations
IFN: interferon; IRGs: IFN-regulated genes; ISGs: IFN-stimulated genes; CEF: 
chicken embryo fibroblasts; rChIFN1: recombinant chicken IFN-α; RIN: RNA 
integrity number; qRT-PCR: quantitative real-time PCR; GAPDH: glyceraldehyde 
3-phosphate dehydrogenase; FC: fold change; FDR: false discovery rate.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ESG and RCC design of the study, data acquisition and analysis, drafting the 
manuscript. NGS data compilation and analysis, drafting the manuscript. CDT 
design, production, curation and maintenance of ChISG Browser website. SG 
design of the study, critically reviewing the manuscript. MAS design of the 
study, data analysis, finalizing manuscript. All authors read and approved the 
final manuscript.
Acknowledgements
We are grateful for the skilled support of Laurence Game, Nathalie Lambie and 
Adam Giess of the Medical Research Council’s (MRC) Clinical Sciences Centre’s 
(CSC) Genomics Facility in conducting microarray analysis and Illumina 
sequencing. We gratefully acknowledge Sarah Butcher and Geraint Barton of 
the Bioinformatics Support Service at Imperial College London for their advice.
Author details
1 Section of Virology, Faculty of Medicine, Imperial College London, St. Mary’s 
Campus, Norfolk Place, London W2 1PG, UK. 2 Faculty of Medicine, Imperial 
College London, London SW7 2AZ, UK. 3 Bioinformatics Support Service, 
Imperial College London, Sir Alexander Fleming Bldg, London SW7 2AZ, UK. 
4 Institute for Infection and Immunity, St. George’s, University of London, 
London SW17 0RE, UK. 
Funding
We wish to acknowledge the UK’s Biotechnology and Biosciences Research 
Council (BBSRC) for funding via grants BB/K002465/1 (“Developing Rapid 
Responses to Emerging Virus Infections of Poultry (DRREVIP)”), BB/H005323/1 
(“Correlation of immunogenicity with microarray analysis of vector mutants to 
improve live recombinant poxvirus vaccines in poultry”) and BB/G018545/1 
(“The avian interferon system and its evasion by Avipoxviruses”).
Availability of data and materials
The datasets supporting the conclusions of this article are available from 
the following repositories: European Bioinformatics Institute (EBI) ArrayEx-
press accession numbers E-MTAB-3711 (for the 32K GeneChip; [42]) and 
E-MTAB-3712 (for the ST array; [43]). European Nucleotide Archive (ENA) study 
number PRJEB7620 (for Illumina RNA-seq; [44]).
Received: 26 April 2016   Accepted: 18 July 2016
References
 1. Randall RE, Goodbourn S (2008) Interferons and viruses: an interplay 
between induction, signalling, antiviral responses and virus counter-
measures. J Gen Virol 89:1–47
 2. Sancho-Shimizu V, Perez de Diego R, Jouanguy E, Zhang SY, Casanova 
JL (2011) Inborn errors of anti-viral interferon immunity in humans. Curr 
Opin Virol 1:487–496
 3. Schneider WM, Chevillotte MD, Rice CM (2014) Interferon-stimu-
lated genes: a complex web of host defenses. Annu Rev Immunol 
32:513–545
 4. Menachery VD, Eisfeld AJ, Schafer A, Josset L, Sims AC, Proll S, Fan S, Li C, 
Neumann G, Tilton SC, Chang J, Gralinski LE, Long C, Green R, Williams 
CM, Weiss J, Matzke MM, Webb-Robertson BJ, Schepmoes AA, Shukla 
AK, Metz TO, Smith RD, Waters KM, Katze MG, Kawaoka Y, Baric RS (2014) 
Pathogenic influenza viruses and coronaviruses utilize similar and 
contrasting approaches to control interferon-stimulated gene responses. 
MBio 5:e01174–01214
Page 12 of 12Giotis et al. Vet Res  (2016) 47:75 
 5. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman 
RH, Williams BR (2001) Functional classification of interferon-stimulated 
genes identified using microarrays. J Leukoc Biol 69:912–920
 6. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice 
CM (2011) A diverse range of gene products are effectors of the type I 
interferon antiviral response. Nature 472:481–485
 7. Isaacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc R 
Soc Lond B Biol Sci 147:258–267
 8. Sekellick MJ, Ferrandino AF, Hopkins DA, Marcus PI (1994) Chicken inter-
feron gene: cloning, expression, and analysis. J Interferon Res 14:71–79
 9. Ko JH, Asano A, Kon Y, Watanabe T, Agui T (2004) Characterization of the 
chicken PKR: polymorphism of the gene and antiviral activity against 
vesicular stomatitis virus. Jpn J Vet Res 51:123–133
 10. International Chicken Genome Sequencing C (2004) Sequence and com-
parative analysis of the chicken genome provide unique perspectives on 
vertebrate evolution. Nature 432:695–716
 11. Downing T, Cormican P, O’Farrelly C, Bradley DG, Lloyd AT (2009) Evidence 
of the adaptive evolution of immune genes in chicken. BMC Res Notes 
2:254
 12. Kim TH, Zhou H (2015) Functional analysis of chicken IRF7 in response to 
dsRNA analog Poly(I:C) by integrating overexpression and knockdown. 
PLoS One 10:e0133450
 13. Magor KE, Miranzo Navarro D, Barber MR, Petkau K, Fleming-Canepa X, 
Blyth GA, Blaine AH (2013) Defense genes missing from the flight division. 
Dev Comp Immunol 41:377–388
 14. Chen S, Cheng A, Wang M (2013) Innate sensing of viruses by pattern 
recognition receptors in birds. Vet Res 44:82
 15. Giotis ES, Robey RR, Ross C, Goodbourn SE, Skinner MA (2015) ID: 217: 
transcriptomic analysis of the chicken interferome [abstract]. Cytokine 
76:104
 16. Buttigieg K, Laidlaw SM, Ross C, Davies M, Goodbourn S, Skinner MA 
(2013) Genetic screen of a library of chimeric poxviruses identifies an 
ankyrin repeat protein involved in resistance to the avian type I interferon 
response. J Virol 87:5028–5040
 17. Long JS, Giotis ES, Moncorge O, Frise R, Mistry B, James J, Morisson M, 
Iqbal M, Vignal A, Skinner MA, Barclay WS (2016) Species difference in 
ANP32A underlies influenza A virus polymerase host restriction. Nature 
529:101–104
 18. ENSEMBL Galgal4.75. http://ftp.ensembl.org/pub/release-75/embl/gal-
lus_gallus. Accessed 26 Apr 2016
 19. Kal AJ, van Zonneveld AJ, Benes V, van den Berg M, Koerkamp MG, 
Albermann K, Strack N, Ruijter JM, Richter A, Dujon B, Ansorge W, Tabak 
HF (1999) Dynamics of gene expression revealed by comparison of serial 
analysis of gene expression transcript profiles from yeast grown on two 
different carbon sources. Mol Biol Cell 10:1859–1872
 20. Baggerly KA, Deng L, Morris JS, Aldaz CM (2003) Differential expression 
in SAGE: accounting for normal between-library variation. Bioinformatics 
19:1477–1483
 21. Venn Diagram Generator. http://www.bioinformatics.lu/venn.php. 
Accessed 26 Apr 2016
 22. Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, Matsuyama T, 
Tanaka N, Kamijo R, Vilcek J, Mak TW, Taniguchi T (1994) Involvement of 
the IRF-1 transcription factor in antiviral responses to interferons. Science 
264:1921–1924
 23. Pine R (1992) Constitutive expression of an ISGF2/IRF1 transgene leads 
to interferon-independent activation of interferon-inducible genes and 
resistance to virus infection. J Virol 66:4470–4478
 24. Stirnweiss A, Ksienzyk A, Klages K, Rand U, Grashoff M, Hauser H, Kroger 
A (2010) IFN regulatory factor-1 bypasses IFN-mediated antiviral effects 
through viperin gene induction. J Immunol 184:5179–5185
 25. Interferome http://interferome.its.monash.edu.au. Accessed 26 Apr 2016
 26. Rusinova I, Forster S, Yu S, Kannan A, Masse M, Cumming H, Chapman R, 
Hertzog PJ (2013) Interferome v2.0: an updated database of annotated 
interferon-regulated genes. Nucleic Acids Res 41:D1040–1046
 27. ChISG Browser. http://cisbic.bioinformatics.ic.ac.uk/skinner. Accessed 26 
Apr 2016
 28. Smith SE, Gibson MS, Wash RS, Ferrara F, Wright E, Temperton N, Kellam 
P, Fife M (2013) Chicken interferon-inducible transmembrane protein 3 
restricts influenza viruses and lyssaviruses in vitro. J Virol 87:12957–12966
 29. NetAffx™ Analysis Center. https://www.affymetrix.com/analysis/index.
affx. Accessed 26 Apr 2016
 30. Himly M, Foster DN, Bottoli I, Iacovoni JS, Vogt PK (1998) The DF-1 chicken 
fibroblast cell line: transformation induced by diverse oncogenes and 
cell death resulting from infection by avian leukosis viruses. Virology 
248:295–304
 31. Giotis ES, Rothwell L, Scott A, Hu T, Talbot R, Todd D, Burt DW, Glass EJ, 
Kaiser P (2015) Transcriptomic profiling of virus-host cell interactions 
following chicken anaemia virus (CAV) infection in an in vivo model. PLoS 
One 10:e0134866
 32. Jang HJ, Lee HJ, Kang KS, Song KD, Kim TH, Song CS, Park MN (2015) 
Molecular responses to the influenza A virus in chicken trachea-derived 
cells. Poult Sci 94:1190–1201
 33. Reemers SS, van Leenen D, Koerkamp MJ, van Haarlem D, van de Haar P, 
van Eden W, Vervelde L (2010) Early host responses to avian influenza A 
virus are prolonged and enhanced at transcriptional level depending on 
maturation of the immune system. Mol Immunol 47:1675–1685
 34. Sarson AJ, Abdul-Careem MF, Zhou H, Sharif S (2006) Transcriptional 
analysis of host responses to Marek’s disease viral infection. Viral Immunol 
19:747–758
 35. Smith J, Sadeyen JR, Butter C, Kaiser P, Burt DW (2015) Analysis of the 
early immune response to infection by infectious bursal disease virus in 
chickens differing in their resistance to the disease. J Virol 89:2469–2482
 36. Smith J, Smith N, Yu L, Paton IR, Gutowska MW, Forrest HL, Danner AF, 
Seiler JP, Digard P, Webster RG, Burt DW (2015) A comparative analysis 
of host responses to avian influenza infection in ducks and chickens 
highlights a role for the interferon-induced transmembrane proteins in 
viral resistance. BMC Genomics 16:574
 37. Vijayakumar P, Mishra A, Ranaware PB, Kolte AP, Kulkarni DD, Burt DW, 
Raut AA (2015) Analysis of the crow lung transcriptome in response 
to infection with highly pathogenic H5N1 avian influenza virus. Gene 
559:77–85
 38. Wang Y, Brahmakshatriya V, Lupiani B, Reddy SM, Soibam B, Benham 
AL, Gunaratne P, Liu HC, Trakooljul N, Ing N, Okimoto R, Zhou H (2012) 
Integrated analysis of microRNA expression and mRNA transcriptome in 
lungs of avian influenza virus infected broilers. BMC Genom 13:278
 39. Yao Y, Zhao Y, Smith LP, Lawrie CH, Saunders NJ, Watson M, Nair V (2009) 
Differential expression of microRNAs in Marek’s disease virus-transformed 
T-lymphoma cell lines. J Gen Virol 90:1551–1559
 40. Laidlaw SM, Robey R, Davies M, Giotis ES, Ross C, Buttigieg K, Goodbourn 
S, Skinner MA (2013) Genetic screen of a mutant poxvirus library identi-
fies an ankyrin repeat protein involved in blocking induction of avian 
type I interferon. J Virol 87:5041–5052
 41. Masuda Y, Matsuda A, Usui T, Sugai T, Asano A, Yamano Y (2012) Biological 
effects of chicken type III interferon on expression of interferon-stimu-
lated genes in chickens: comparison with type I and type II interferons. J 
Vet Med Sci 74:1381–1386
 42. EMBL-EBI ArrayExpress E-MTAB-3711. http://www.ebi.ac.uk/arrayexpress/
experiments/E-MTAB-3711. Accessed 26 Apr 2016
 43. EMBL-EBI ArrayExpress E-MTAB-3712. http://www.ebi.ac.uk/arrayexpress/
experiments/E-MTAB-3712. Accessed 26 Apr 2016
 44. EBI ENA PRJEB7620. http://www.ebi.ac.uk/ena/data/
search?query=PRJEB7620. Accessed 26 Apr 2016
 45. Interferome. http://www.interferome.org/interferome. Accessed 26 Apr 
2016
 46. The HUGO Gene Nomenclature Committee. http://www.genenames.org. 
Accessed 26 Apr 2016
 47. Mouse Genome Informatics. http://www.informatics.jax.org/marker/. 
Accessed 26 Apr 2016
